Have a personal or library account? Click to login
Cessation of Renin-Angiotensin System Antagonists During the SARS-CoV-2 Pandemic – Do We Have the Evidence? Cover

Cessation of Renin-Angiotensin System Antagonists During the SARS-CoV-2 Pandemic – Do We Have the Evidence?

Open Access
|Oct 2020

Authors

Emanuel Blîndu

emi.blindu@yahoo.com

Clinic of Cardiology, Emergency Clinical County Hospital, Târgu Mureş, Romania

Renata Gerculy

gerculy_renata@yahoo.com

Clinic of Cardiology, Emergency Clinical County Hospital, Târgu Mureş, Romania

Diana Opincariu

diana.opincariu@yahoo.com

Clinic of Cardiology, Emergency Clinical County Hospital, Târgu Mureş, Romania
”George Emil Palade” University of Medicine, Pharmacy, Science and Technology, Târgu Mureş, Romania
Center of Advanced Research in Multimodality Cardiac Imaging, CardioMed Medical Center, Târgu Mureş, Romania

Daniel Cernica

daniel.cernica@gmail.com

Clinic of Cardiology, Emergency Clinical County Hospital, Târgu Mureş, Romania
”George Emil Palade” University of Medicine, Pharmacy, Science and Technology, Târgu Mureş, Romania
Center of Advanced Research in Multimodality Cardiac Imaging, CardioMed Medical Center, Târgu Mureş, Romania

Imre Benedek

imrebenedek@yahoo.com

Clinic of Cardiology, Emergency Clinical County Hospital, Târgu Mureş, Romania
”George Emil Palade” University of Medicine, Pharmacy, Science and Technology, Târgu Mureş, Romania
Center of Advanced Research in Multimodality Cardiac Imaging, CardioMed Medical Center, Târgu Mureş, Romania
DOI: https://doi.org/10.2478/jim-2020-0022 | Journal eISSN: 2501-8132 | Journal ISSN: 2501-5974
Language: English
Page range: 105 - 109
Submitted on: Jul 17, 2020
|
Accepted on: Aug 15, 2020
|
Published on: Oct 20, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 Emanuel Blîndu, Renata Gerculy, Diana Opincariu, Daniel Cernica, Imre Benedek, published by Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.